An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays come in many different formats and variations, and may be run in multiple steps with reagents being added and washed away or separated at different points in the assay. Credit: Shutterstock
-
Rapid urinary antigen testing is widely used for pneumonia diagnosis, yet it often lacks the consistency and traceability required in today’s clinical laboratories. This webinar explor...
Traumatic brain injury, together with adjacent brain conditions such as Alzheimer’s disease, is a global health crisis. In this presentation, Aleksandra Hemm, Product Manager from Ther...
Bio-Techne is proud to provide a first glimpse into the power and performance of the Leo™ System using several assay models as it hits the market. Data highlights include throughput, s...
Analyzing protein expression in biological samples has traditionally been challenging and often poorly reproducible. While methods like western blot have been around for decades, Simple West...
This webinar will demonstrate how the MANTIS and TEMPEST liquid dispensers enable assay automation and miniaturization in various applications such as PCR, NGS, immunoassays, and cell and or...
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
Luminex and Thermo Fisher Scientific are excited to feature two presentations highlighting the advanced features of the Invitrogen™ Luminex® xMAP® INTELLIFLEX™ DR-SE inst...
Proliferation biomarkers are proteins that are up-regulated in growing cells. Immunological staining of tumor tissue can provide an indication of the aggressivity of the tumor and provide in...
The accurate and timely detection of disease biomarkers at the point-of-care is essential to ensure effective treatment and prevention of diseases....
Hematuria (blood in urine) may occur in up to 10% of the general population and results in costly evaluation to ensure it is of no consequence, i.e., no bladder cancer (BCa) is present since...